CABA
USDCabaletta Bio Inc. Common Stock
Цена в режиме реального времени
График цен
Ключевые показатели
Рыночные показатели
Открытие
$2.860
Максимум
$2.970
Минимум
$2.630
Объем
3.67M
Фундаментальные показатели компании
Рыночная капитализация
247.0M
Отрасль
Биотехнология
Страна
United States
Статистические данные торговли
Средний объем
3.63M
Биржа
NMS
Валюта
USD
52-недельный диапазон
Связанные новости
Cabaletta Bio Reports Third Quarter 2025 Financial Results and Provides Business Update
Rese-cel data presented at multiple medical meetings demonstrated potentially transformative, drug-free clinical responses with a favorable safety profile for autoimmune patients supporting outpatient use All myositis
FDA's Rigid Approach Adds Uncertainty To uniQure's Accelerated Pathway For Huntington's Gene Therapy
William Blair notes FDA's tougher stance on gene therapy programs as AMT-130 faces uncertainty in its accelerated approval timeline.
Cantor Fitzgerald Maintains Overweight on Cabaletta Bio, Raises Price Target to $30
Cantor Fitzgerald analyst Josh Schimmer maintains Cabaletta Bio with a Overweight and raises the price target from $15 to $30.
Cabaletta Bio Presents Positive Clinical Data and Development Updates for Rese-cel at ACR Convergence 2025
– All myositis patients in the Phase 1/2 DM/ASyS cohort with sufficient follow-up who met key registrational inclusion criteria exceeded the registrational primary endpoint, demonstrating major TIS responses with no
Связанные акции
PRDO
Perdoceo Education Corporation
IH
iHuman Inc. American depositary shares each representing five ordinary shares
AVGR
Avinger Inc.
KVYO
Klaviyo Inc. Series A
CLOER
Clover Leaf Capital Corp. Rights
Оставаться в курсе
Установите ценовой сигнал, получите обновления анализа ИИ и новости рынка в режиме реального времени.